Found 51 matching trials
A Study to Evaluate Sacituzumab Tirumotecan (MK-2870) in Advanced/Metastatic Gastroesophageal Adenocarcinoma (MK-2870-015) PHASE3 This study will compare how safe and effective sacituzumab tirumotecan is v...
Show More Status
Active Not Recruiting
Location
Banner MD Anderson Cancer Center ( Site 0119)
Learn More & Join Trial
Safety and Blood Immune Cell Study of Anakinra Plus Physician's Chemotherapy Choice in Metastatic Breast Cancer Patients PHASE1 To determine the safety of administering anakinra plus the physician's chem...
Show More Location
Baylor University Medical Center
Learn More & Join Trial
Famitinib in Combination With Camrelizumab and TPC in The First-line Treatment of Immunomodulatory Locally Advanced or Metastatic TNBC. PHASE3 The study is being conducted to evaluate the Famitinib with Camrelizumab pl...
Show More Location
Breast cancer institute of Fudan University Cancer Hospital
Learn More & Join Trial
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032) PHASE3 Researchers are looking for new ways to treat types of breast cancer that a...
Show More Location
Banner MD Anderson Cancer Center ( Site 0066)
Learn More & Join Trial
A Clinical Study of Boserolimab (MK-5890) With Pembrolizumab and Chemotherapy in People With Early Triple-Negative Breast Cancer (MK-5890-003) PHASE2 Researchers want to learn if giving boserolimab (MK-5890) with standard tre...
Show More Location
Optum Care Cancer Center ( Site 0004)
Learn More & Join Trial
A Study of Pyrotinib Plus Vinorelbine in Comparison With Treatment of Physician's Choice in Participants With HER2-positive Locally Advanced or Metastatic Breast Cancer PHASE2 The purpose of this study is to identify the highest tolerable dose of pyro...
Show More Location
Multiple Locations
Learn More & Join Trial
Study of Sacituzumab Govitecan-hziy Versus Treatment of Physician's Choice in Participants With HR+/HER2- Metastatic Breast Cancer PHASE3 The primary objective of this study is to assess and compare the efficacy a...
Show More Location
HonorHealth Research Institute
Learn More & Join Trial
Study of Sacituzumab Govitecan-hziy Versus Treatment of Physician's Choice in Patients With Previously Untreated Locally Advanced Inoperable or Metastatic Triple-Negative Breast Cancer PHASE3 The primary objective of this study is to compare the progression-free surv...
Show More Status
Active Not Recruiting
Location
Arizona Oncology Associates, PC-Hope,1845 W Orange Grove Rd
Learn More & Join Trial
A Study of MHB088C Injection Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer PHASE3 This study was designed to compare the efficacy and safety of MHB088C for I...
Show More Location
Shanghai East Hospital
Learn More & Join Trial
A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016) PHASE3 Researchers are looking for other ways to treat breast cancer (BC) that is ...
Show More Location
Southern Cancer Center (SCC) ( Site 8000)
Learn More & Join Trial